Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Germany Ready to Step On The Gas For Medtech But Reimbursement Delays Still Block The Road

Executive Summary

After very complex national elections in 2017, Jens Spahn (CDU) emerged from the confusion holding the health portfolio. He is now ready to broach the trickier elements of his role, including finding solutions for the currently lengthy reimbursement delays for innovative medtech, which is a top priority for local manufacturers.

You may also be interested in...



German Health-Care Policymaking Back On Track As Coalition Comes Together

Germany's center-left SPD party will be the junior partner in the new government after 66% of party members voted in favor of another coalition with the center-right Christian Union parties led by Angela Merkela. Jens Spahn, who is in Merkel's party but not in her inner circle, has already been given the health portfolio.

GERMANY UP CLOSE: Telehealth Gets A Small But Vital Place In Telematic Infrastructure

Germany’s eHealth law has had its first reading in the lower house and is on its way into law, with the enthusiastic backing of the health ministry. But users of telehealth applications and the medical devices industry think it does not go far enough or fast enough, as ZVEI* medical engineering managing director Hans-Peter Bursig tells Clinica

UK IVDs Firms Working Flat Out On COVID-19 Tests, As Govt Promises Test Capacity Increase

Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.

Topics

UsernamePublicRestriction

Register

MT123342

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel